These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35117796)

  • 21. Cytokeratin-based CTC counting unrelated to clinical follow up.
    Chinen LT; de Carvalho FM; Rocha BM; Aguiar CM; Abdallah EA; Campanha D; Mingues NB; de Oliveira TB; Maciel MS; Cervantes GM; Dettino AL; Soares FA; Paterlini-Bréchot P; Fanelli MF
    J Thorac Dis; 2013 Oct; 5(5):593-9. PubMed ID: 24255771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer.
    Ilié M; Szafer-Glusman E; Hofman V; Chamorey E; Lalvée S; Selva E; Leroy S; Marquette CH; Kowanetz M; Hedge P; Punnoose E; Hofman P
    Ann Oncol; 2018 Jan; 29(1):193-199. PubMed ID: 29361135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.
    Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q
    J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
    Lu J; Fan T; Zhao Q; Zeng W; Zaslavsky E; Chen JJ; Frohman MA; Golightly MG; Madajewicz S; Chen WT
    Int J Cancer; 2010 Feb; 126(3):669-83. PubMed ID: 19662651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs).
    Kallergi G; Politaki E; Alkahtani S; Stournaras C; Georgoulias V
    Cell Physiol Biochem; 2016; 40(3-4):411-419. PubMed ID: 27889762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
    Khoja L; Backen A; Sloane R; Menasce L; Ryder D; Krebs M; Board R; Clack G; Hughes A; Blackhall F; Valle JW; Dive C
    Br J Cancer; 2012 Jan; 106(3):508-16. PubMed ID: 22187035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells.
    Souza E Silva V; Chinen LT; Abdallah EA; Damascena A; Paludo J; Chojniak R; Dettino AL; de Mello CA; Alves VS; Fanelli MF
    Onco Targets Ther; 2016; 9():7503-7513. PubMed ID: 28008271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells.
    Vona G; Sabile A; Louha M; Sitruk V; Romana S; Schütze K; Capron F; Franco D; Pazzagli M; Vekemans M; Lacour B; Bréchot C; Paterlini-Bréchot P
    Am J Pathol; 2000 Jan; 156(1):57-63. PubMed ID: 10623654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients.
    Abdallah EA; Fanelli MF; Buim ME; Machado Netto MC; Gasparini Junior JL; Souza E Silva V; Dettino AL; Mingues NB; Romero JV; Ocea LM; Rocha BM; Alves VS; Araújo DV; Chinen LT
    Int J Cancer; 2015 Sep; 137(6):1397-405. PubMed ID: 25721610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer.
    Pailler E; Auger N; Lindsay CR; Vielh P; Islas-Morris-Hernandez A; Borget I; Ngo-Camus M; Planchard D; Soria JC; Besse B; Farace F
    Ann Oncol; 2015 Jul; 26(7):1408-15. PubMed ID: 25846554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
    Jiang S; Mao C; Jiang B; Tan Q; Deng B
    Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
    Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
    Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting.
    Zhang Q; Xu K; Chen M; Miao Y; Wang N; Xu Z; Xu H
    Saudi J Gastroenterol; 2020; 26(3):160-167. PubMed ID: 32386192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method.
    Sun N; Li X; Wang Z; Li Y; Pei R
    Biosens Bioelectron; 2018 Apr; 102():157-163. PubMed ID: 29132051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
    Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review.
    Khatami F; Aghayan HR; Sanaei M; Heshmat R; Tavangar SM; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):175-193. PubMed ID: 28282718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.